Fidelis Capital Partners’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$577K Buy
8,164
+855
+12% +$64K 0.04% 301
2025
Q4
$577K Buy
7,309
+558
+8% +$44.2K 0.04% 283
2025
Q3
$556K Buy
6,751
+3,138
+87% +$247K 0.04% 280
2025
Q2
$274K Buy
3,613
+180
+5% +$13.9K 0.03% 365
2025
Q1
$258K Sell
3,433
-39
-1% -$3.24K 0.03% 349
2024
Q4
$297K Buy
3,472
+228
+7% +$19K 0.03% 334
2024
Q3
$273K Sell
3,244
-70
-2% -$5.23K 0.03% 335
2024
Q2
$228K Sell
3,314
-138
-4% -$9.85K 0.03% 331
2024
Q1
$256K Buy
+3,452
New +$241K 0.04% 318
2023
Q4
Sell
-3,686
Closed -$232K 335
2023
Q3
$232K Buy
+3,686
New +$230K 0.08% 236

Other funds holding MET

Fidelis Capital Partners's MET Position: Q1 2026 in Review

Fidelis Capital Partners increased its MetLife (MET) stake by 12% in Q1 2026, buying an estimated $64K and bringing the position to 8,164 shares worth $577K. The position accounts for 0.04% of the portfolio, ranked #301.

Fidelis Capital Partners first reported a position in MET in Q3 2023 and has held it in 10 quarters since. 1,371 funds tracked by Wall St. Rank hold MET as of Q1 2026.

  • Fidelis Capital Partners held 8,164 shares of MetLife worth $577K as of Q1 2026.
  • Fidelis Capital Partners bought 855 MetLife shares in Q1 2026, an estimated $64K.
  • MetLife made up 0.04% of Fidelis Capital Partners's portfolio in Q1 2026, its #301 holding.
  • Fidelis Capital Partners first reported a position in MetLife in Q3 2023 and has held it in 10 quarters since.
  • 1,371 funds tracked by Wall St. Rank held MetLife as of Q1 2026.

Based on Fidelis Capital Partners's 13F filing for Q1 2026, filed 6 May 2026.